The percentages of CD134+CD4+ T-cells were significantly increased in SLE patients as compared to healthy controls (21.4 ± 10.4% vs. 13.7 ± 5.8%; p = 0.002). This evidence concerns the gene TNFRSF4 and systemic lupus erythematosus.